Fierce Medtech Names Komodo Health Among “Fierce 15” Med Tech Companies of 2021
Komodo Health Recognized for Its Powerful Technology and Data-Driven Approach to Democratize Patient Insights
San Francisco, CA – March 8, 2022 – Komodo Health today announced that it has been named by Fierce Medtech as one of the publication’s Fierce 15 med tech companies, designating it as one of the most promising private med tech companies in the industry.
Komodo Health is a fast-growing technology company that is increasingly recognized as the most reliable source of patient-centric insights. In the company’s mission to reduce the global burden of disease, Komodo empowers the entire healthcare and Life Sciences ecosystem with patient-centric analytics at scale, placing the patient at the center of healthcare by offering a way to understand and take action on unmet patient needs. As healthcare becomes increasingly complex, Komodo addresses some of healthcare’s biggest challenges, both for patients and those who serve them.
“To be recognized in this year’s Fierce 15, among this cohort of incredible tech companies, is very humbling and tells us that others believe in our mission and the work we’re doing to reduce the burden of disease,” said Web Sun, President and Co-founder of Komodo Health. “As a next-generation enterprise data and software company, we are creating a new standard for real-world data and analytics that can help unlock a more complete understanding of individual patient journeys across the entire healthcare ecosystem.”
The Fierce 15 celebrates the spirit of being “fierce” – championing innovation and creativity, even in the face of intense competition. This is Fierce Medtech’s 10th annual Fierce 15 selection. This year’s full list of winners can be viewed online here.
Komodo offers some of the industry’s most critical and differentiated insights, for example in identifying rare disease signals, understanding healthcare disparities, pinpointing referral patterns, and more. Despite the challenges of the COVID-19 pandemic, the company has expanded its software capabilities, invested in its Healthcare Map™, and continued to expand its client base.
“While we’re not fully out of the woods yet when it comes to COVID-19, the innovations pursued by this year’s class of 15 companies will help the industry evolve, either in step with the pandemic or in spite of it,” said Conor Hale, senior editor of Fierce Medtech.
An internationally recognized daily report reaching a network of over 90,000 med tech industry professionals, Fierce Medtech provides subscribers with an authoritative analysis of the day's top stories. Every year, Fierce Medtech evaluates hundreds of private companies from around the world for its annual Fierce 15 list, which is based on a variety of factors such as the strength of a company’s technology, partnerships, venture backers, and competitive market position.
About Fierce Medtech
Fierce Medtech keeps biopharma executives, device developers, engineers, and researchers updated on the must-know news, trends, and developments in medical technology. More than 90,000 top industry professionals rely on Fierce Medtech for an insider briefing on the day’s top stories.
About Komodo Health
Komodo Health builds groundbreaking software solutions powered by our Healthcare Map – the industry’s largest and most comprehensive view of real-world, patient journey data. Komodo’s next-generation analytics make it easy to unlock meaningful insights and create more cost-effective, value-driven solutions that improve patient outcomes. In our mission to reduce the global burden of disease, we help healthcare and Life Sciences enterprises answer healthcare’s most complex questions. For more information, visit komodohealth.com.